XUCS:F:F- (EUR)

ETF | Others |

Last Closing

USD 41.235

Change

+0.15 (+0.35)%

Market Cap

USD 0.09B

Volume

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.20 (+0.74%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.79%)

USD 117.56B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.43 (+0.78%)

USD 95.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.36 (-0.07%)

USD 89.53B
EUNL:F iShares Core MSCI World UCITS ..

N/A

USD 72.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.15 (+0.66%)

USD 71.25B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.95 (+0.41%)

USD 56.96B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 56.02B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.07 (+0.07%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.08 (+0.09%)

USD 51.63B

ETFs Containing XUCS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.42% 76% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.42% 74% C 64% D
Trailing 12 Months  
Capital Gain 9.15% 51% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.15% 48% F 53% F
Trailing 5 Years  
Capital Gain 45.96% 68% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.96% 68% D+ 55% F
Average Annual (5 Year Horizon)  
Capital Gain 6.61% 66% D+ 65% D
Dividend Return 6.61% 65% D 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.53% 61% D- 84% B
Risk Adjusted Return 62.76% 82% B 85% B
Market Capitalization 0.09B 25% F 29% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.